The biotech industry plays a crucial role in advancing healthcare through innovative therapies, genetic research, and drug development. The sector is driven by the demand for therapeutic treatments and genetic disorders cures, which is gaining momentum in the market.
Amid this, it could be wise to invest in fundamentally sound small-cap biotech stocks, Esperion Therapeutics, Inc. (ESPR), Innoviva, Inc. (INVA), and SIGA Technologies, Inc. (SIGA), with game-changing potential.
-copy-29e15046.jpeg?w=600)
